132 related articles for article (PubMed ID: 2783335)
1. Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.
Shimizu S; Yoshioka R; Hirose Y; Sugai S; Tachibana J; Konda S
J Exp Med; 1989 Jan; 169(1):339-44. PubMed ID: 2783335
[TBL] [Abstract][Full Text] [Related]
2. BSF-2/IL-6 does not augment Ig secretion but stimulates proliferation in myeloma cells.
Tanabe O; Kawano M; Tanaka H; Iwato K; Asaoku H; Ishikawa H; Nobuyoshi M; Hirano T; Kishimoto T; Kuramoto A
Am J Hematol; 1989 Aug; 31(4):258-62. PubMed ID: 2787116
[TBL] [Abstract][Full Text] [Related]
3. Role of interleukin 6 in the growth of myeloma-derived cell lines.
Barut BA; Zon LI; Cochran MK; Paul SR; Chauhan D; Mohrbacher A; Fingeroth J; Anderson KC
Leuk Res; 1992 Oct; 16(10):951-9. PubMed ID: 1405708
[TBL] [Abstract][Full Text] [Related]
4. Lack of a role of interleukin 11 in the growth of multiple myeloma.
Paul SR; Barut BA; Bennett F; Cochran MA; Anderson KC
Leuk Res; 1992; 16(3):247-52. PubMed ID: 1532843
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of four myeloma cell lines which are responsive to interleukin-6 for their growth.
Okuno Y; Takahashi T; Suzuki A; Ichiba S; Nakamura K; Fukumoto M; Okada T; Okada H; Imura H
Leukemia; 1991 Jul; 5(7):585-91. PubMed ID: 2072743
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma.
Kawano M; Tanaka H; Ishikawa H; Nobuyoshi M; Iwato K; Asaoku H; Tanabe O; Kuramoto A
Blood; 1989 Jun; 73(8):2145-8. PubMed ID: 2786435
[TBL] [Abstract][Full Text] [Related]
7. [The mechanisms of myeloma cell growth].
Shimizu S
Nihon Rinsho; 1995 Mar; 53(3):557-63. PubMed ID: 7699885
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6.
Westendorf JJ; Ahmann GJ; Greipp PR; Witzig TE; Lust JA; Jelinek DF
Leukemia; 1996 May; 10(5):866-76. PubMed ID: 8656685
[TBL] [Abstract][Full Text] [Related]
9. Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-My 1 to 7 established from patients with advanced stage of the disease.
Hitzler JK; Martinez-Valdez H; Bergsagel DB; Minden MD; Messner HA
Blood; 1991 Oct; 78(8):1996-2004. PubMed ID: 1912582
[TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of multiple myeloma cell growth].
Simizu S; Konda S
Rinsho Ketsueki; 1993 Apr; 34(4):418-22. PubMed ID: 8510327
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal anti-human IL-6 receptor antibody inhibits the proliferation of human myeloma cells.
Huang YW; Vitetta ES
Hybridoma; 1993 Oct; 12(5):621-30. PubMed ID: 8300137
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 (B-cell stimulatory factor 2)-dependent growth of a Lennert's lymphoma-derived T-cell line (KT-3).
Shimizu S; Hirano T; Yoshioka R; Sugai S; Matsuda T; Taga T; Kishimoto T; Konda S
Blood; 1988 Nov; 72(5):1826-8. PubMed ID: 3052631
[TBL] [Abstract][Full Text] [Related]
13. Requirement of soluble factors produced by bone marrow stromal cells on the growth of novel established human myeloma cell line.
Aikawa S; Hatta Y; Tanaka M; Kaneita Y; Yasukawa K; Sawada U; Horie T; Tsuboi I; Aizawa S
Int J Oncol; 2003 Mar; 22(3):631-7. PubMed ID: 12579318
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
Klein B; Zhang XG; Jourdan M; Boiron JM; Portier M; Lu ZY; Wijdenes J; Brochier J; Bataille R
Eur Cytokine Netw; 1990; 1(4):193-201. PubMed ID: 2104241
[TBL] [Abstract][Full Text] [Related]
15. [Cytokines and lymphoplasmocytic proliferations: essential role of interleukin 6].
Bataille R; Klein B
Rev Prat; 1993 Feb; 43(3):275-8. PubMed ID: 8502954
[TBL] [Abstract][Full Text] [Related]
16. Human bone marrow stroma-dependent myeloma sister cell lines MOLP-6 and MOLP-7 derived from a patient with multiple myeloma.
Harashima A; Matsuo Y; Nishizaki C; Kozuka T; Fukuda S; Sezaki T; Orita K
Hum Cell; 2000 Mar; 13(1):43-54. PubMed ID: 10937346
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma.
Zhang XG; Klein B; Bataille R
Blood; 1989 Jul; 74(1):11-3. PubMed ID: 2787674
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.
Nishimoto N; Ogata A; Shima Y; Tani Y; Ogawa H; Nakagawa M; Sugiyama H; Yoshizaki K; Kishimoto T
J Exp Med; 1994 Apr; 179(4):1343-7. PubMed ID: 8145046
[TBL] [Abstract][Full Text] [Related]
19. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.
Klein B; Zhang XG; Jourdan M; Content J; Houssiau F; Aarden L; Piechaczyk M; Bataille R
Blood; 1989 Feb; 73(2):517-26. PubMed ID: 2783861
[TBL] [Abstract][Full Text] [Related]
20. IFN-alpha induces autocrine production of IL-6 in myeloma cell lines.
Jourdan M; Zhang XG; Portier M; Boiron JM; Bataille R; Klein B
J Immunol; 1991 Dec; 147(12):4402-7. PubMed ID: 1753108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
